Healthcare >> Analyst Interviews >> July 28, 2003

Small Cap Biotechnology Companies: Russell Gilbertson – Roth Capital Partners Llc

DR. RUSSELL GILBERTSON joined the healthcare team of Roth Capital Partners in January 2003 as a Research Analyst and covers the biotechnology sector. He has appeared on CNBC and is often quoted by Dow Jones News Wires and Bloomberg. Dr. Gilbertson served 20 years as a clinical physician in anesthesiology and internal medicine, working in Los Angeles and New York City. He graduated from the University of Wisconsin-Madison, Phi Beta Kappa with a focus on immunology. He also earned his medical degree at the University of Wisconsin. He received an Executive Master's of Finance from Baruch College, Zicklin School of Business in New York with the distinction of Beta Gamma Sigma. Profile
TWST: Could we start out with a quick overview of your coverage?

Dr. Gilbertson: I currently cover 10 companies and they vary in

magnitude of market cap. I cover Amgen (AMGN), which of course